Abstract Duckweeds ( Lemnaceae ), the smallest and fastest-growing flowering plants, have emerged as a transformative platform for sustainable biotechnology. This review synthesizes recent advances that underpin their potential as a next-generation plant chassis. We discuss duckweed's unique biology, characterized by reductive evolution, extreme phenotypic plasticity, and a simplified epigenome that favors transgene expression. The decoding of its minimalist genome, along with the establishment of efficient genetic tools including optimized transformation and CRISPR-Cas9 editing, enables precise genetic and metabolic engineering. While traditional uses in phytoremediation and animal feed validate its utility, duckweed's rapid growth in contained, soil-free culture and its edibility offer distinct advantages for molecular farming over established systems like tobacco. We highlight progress in engineering duckweeds to produce vaccines, therapeutic proteins, and high-value metabolites. To transition from proof-of-concept to an industrial workhorse, future efforts must focus on integrated omics databases, universal genetic toolkits, and scalable cultivation. Converging fundamental insights with synthetic biology principles positions duckweed as a versatile and powerful chassis for the bioeconomy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yin et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69e1ceaa5cdc762e9d857b60 — DOI: https://doi.org/10.1007/s44307-026-00110-1
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
Gui-Min Yin
Lin Yang
Sha Li
Advanced Biotechnology
Building similarity graph...
Analyzing shared references across papers
Loading...